Critique of the video What works well Where it falls short Accessible risk framing Greger repeatedly converts relative risks to absolute numbers and NNH, helping lay listeners grasp scale
This will allow the injection to work its way through the body, to achieve the greatest results when using this injection for weight loss purposes
The widely repeated claim that Dihexa is "seven orders of magnitude more potent than BDNF" originates from that flagged McCoy paper and reflects an assay-specific in-vitro spine-density measurement picomolar Dihexa versus nanomolar BDNF in one assay not a millions-fold advantage in a living brain
"Queen Cardi B: The people's pop culture icon"
(PubMed) Wilhelm SM, Rjater RG, Kale-Pradhan PB
Danuglipron Danuglipron is a small-molecule GLP-1 receptor agonist, formerly under development by Pfizer [1] that, in an oral formulation, was under investigation as a therapy for diabetes mellitus